G

Gaudium IVF and Women Health Ltd.

BSE
ListedListed on 27 Feb 2026+5.1%

₹75–79

₹ 116 Cr

189 Shares

₹ 14,175

₹5

Financial Summary

Consolidated(in ₹ million)
ParticularsFY 2024-25FY 2023-24
7,072.44,789.01
23.4426.3
7,095.844,815.31
4,184.512,845.06
2,542.251,663.16
1,912.741,031.69

Subscription Details

7.27xTotal
Subscription
7.60x
14.05x
1.62x
0.00x

IPO Timeline

IPO Offer Start

20 Feb 2026

IPO Offer Ends

24 Feb 2026

27 Feb 2026

Use of Proceeds

#PurposeAmount (₹ Million)
1Funding capital expenditure towards establishment of New IVF Centers of our Company500
2Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company200

Promoters

Manika KhannaPeeyush KhannaVishad Khanna

Book Running Lead Managers

Sarthi Capital Advisors Pvt Ltd.

Promoter Shareholding

Pre-IPO

99.98%

Promoter stake

Post-IPO

71.29%

Promoter stake

Offered to Public

2,08,86,200

shares

Post Share Capital

5,18,91,384

shares

About the Company

Parenthood is a joyful journey, especially for mothers who experiences motherhood. We understand the challenges couples face in building a family due to infertility, medical issues, or lifestyle factors. Our mission is to help make their dream of parenthood come true through personalized fertility treatments. From the first consultation to a successful pregnancy, we provide expert care, support, and a close partnership with our patients, ensuring a hopeful and joyful future.

Use of Proceeds

1) Funding capital expenditure towards establishment of New IVF Centers of our Company. 2) Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company. 3) General Corporate Purposes.